Abstract. Erythropoietin (EPO) is a hematopoietic growth factor that stimulates proliferation and differentiation of erythroid precursor cells and is also known to exert neurotrophic activity in the central nervous system (CNS). However, little is known about expression of EPO and EPO receptor (EPOR) in human CNS tissues. In the present study, we investigated the effects of proinflammatory cytokines on EPO and EPOR expression in highly purified cultures of human neurons, astrocytes, microglia, and oligodendrocytes using reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). EPO mRNA was demonstrated only in human astrocytes, while EPOR expression was found in human neurons, astrocytes, and microglia. Neither EPO nor EPOR expression was found in oligodendrocytes. In human astrocytes, EPO mRNA and secreted EPO protein levels were downregulated after exposure to proinflammatory cytokines (IL-1␤, IL-6, or TNF-␣). In human neurons, TNF-␣ treatment markedly increased EPOR expression. These results suggest that proinflammatory cytokines regulate expression of EPO and EPOR in human neurons, astrocytes, and microglia and further facilitate interactions among different cell types in the human CNS.
INTRODUCTION
Erythropoietin (EPO) is a hematopoietic growth factor produced in kidney and fetal liver, and stimulates proliferation and differentiation of erythroid precursor cells (1) (2) (3) . EPO production in the central nervous system (CNS) is controlled by oxygen tension and tissue hypoxia or lowered respiratory oxygen pressure causes an increase in EPO production in the CNS (3) .
Recent studies have reported that EPO shows neurotrophic activity in the CNS. EPO is known to produce trophic effects on rat cholinergic neurons (4), prevents ischemia-induced neuronal cell death in rat hippocampus (5) , and protects cultured rat cortical neurons (6) . EPO is produced in astrocytes and EPO receptor (EPOR) expression has been demonstrated in rat hippocampal neurons (7, 8) . It appears that EPO produced in astrocytes acts on CNS neurons in a paracrine fashion to induce neurotrophic effect (9) .
Proinflammatory cytokines such as interleukin 1 (IL-1) and tumor necrosis factors (TNFs) inhibit EPO production in human hepatoma cell lines (10) (11) (12) and in isolated rat kidneys (11, 13) . It is a matter of great interest to know how EPO or EPOR expression in the CNS is controlled by cytokines or other macromolecules in health and disease states in which cytokines are generated.
In the present study, expression of EPO and EPOR in enriched cultures of human neurons, astrocytes, microglia, and oligodendrocytes was investigated by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA).
MATERIALS AND METHODS

Human Neurons and Glial Cells in Culture
Four series of primary culture were prepared from embryonic human brains at 12 to 15 weeks' gestation, as described previously (14) (15) (16) . The use of embryonic tissue samples was approved by the Ethics Committee of the University of British Columbia Faculty of Medicine. Brains were dissected into small blocks and incubated in phosphate-buffered saline (PBS) containing 0.25% trypsin and 40 g/ml DNAse I for 30 min at 37ЊC. Dissociated cells were suspended in Dulbecco's modified Eagle medium (DMEM) supplemented with 5% horse serum, 5% fetal bovine serum, 5 mg/ml glucose, 20 g/ml gentamicin, and 2.5 g/ml amphotericin B (feeding medium), plated at a density of 10 6 cells/ml in T75 culture flasks, and incubated at 37ЊC in an incubator with 5% CO 2 /95% air atmosphere. After 2 to 4 wk, cells grown in the flasks consisted of a confluent basal layer of flat astrocytes, free-floating microglia, and small, round or ovoid neurons on top of the astrocyte layer. Microglia floating in the medium were collected and plated on coverslips or dishes at appropriate densities. For isolation of neuron-enriched populations, small neurons on top of the basal astrocyte layer were detached by mechanical shaking on an orbital shaker at 250 rpm overnight and collected. In order to enrich the neuronal population, cultures were exposed to 5 ϫ 10 Ϫ4 M each of 5Ј-fluoro-2Ј-deoxyuridine (FrdU; Sigma, St. Louis, MO) and uridine (Sigma) for 24 h on the fourth and seventh days in culture. After neurons and a small 387 
number of oligodendrocytes were removed by vigorous shaking, astrocyte-enriched cell preparations were obtained from plastic surface-adherent cells by a brief incubation in PBS containing 0.1% trypsin and 1 mM EDTA. Cultures of human oligodendrocytes from adult brains were established using an enzyme digestion-Percoll density gradient method as previously described (17, 18) . Human brain was obtained from patients undergoing partial temporal lobe resection for intractable epilepsy. Brain tissue was minced and incubated in 0.25% trypsin and 20 g/ml DNase in PBS for 40 min at 36ЊC. Dissociated cells were passed through a 100 m nylon mesh, suspended in PBS, mixed with Percoll (Pharmacia Biotech, Uppsala, Sweden), and then centrifuged in a 30% Percoll gradient. An oligodendrocyte layer was collected, washed, and suspended in feeding medium. Twenty-four hours (h) after plating, most oligodendrocytes were not attached to the plastic surface, while other cell types such as astrocytes and microglia were attached. The floating cells were collected and plated.
To confirm the purity of cell preparation, all cell type-enriched cultures were processed for immunolabeling with cell type-specific markers: ␤-tubulin isotype III for neurons, glial fibrillary acidic protein (GFAP) for astrocytes, Ricinus communis agglutinin-1 (RCA-1) for microglia, and galactocerebroside (GalC) for oligodendrocytes. Mouse anti-␤-tubulin isotype III monoclonal antibody, rabbit anti-GFAP antibody, and biotinylated RCA-1 were obtained from Sigma. Mouse anti-GalC monoclonal antibody was obtained from a hybridoma cell line grown in our laboratory (19) . Immunocytochemistry was performed according to the methods described previously (14, 20) .
Treatment with Cytokines
To examine the regulation of EPO and EPOR gene expression and protein secretion of EPO, cultures were incubated in feeding medium alone or medium containing the following recombinant human proinflammatory cytokines: IL-1␤ (10 ng/ml, R&D Systems, Minneapolis, MN); IL-6 (10 ng/ml, Peprotech, Rocky Hill, NJ); or TNF-␣ (10 ng/ml, Peprotech). We also treated cultures with recombinant human IL-10 (10 ng/ml, Peprotech), which attenuates astroglial reactivity (21, 22) . The optimal concentrations of cytokines used in the present study were derived from preliminary experiments conducted using 3 graded concentrations: 50, 10, and 2 ng/ml. The results indicated that cytokines at 10 ng/ml concentration were satisfactory for our experiment.
RT-PCR Analysis
Total RNA was extracted using TRIzol reagent (GIBCO-BRL, Gaithersburg, MD). Complimentary DNA (cDNA) templates from each sample were prepared from 2 g of total RNA primed with oligo dT primers (Pharmacia, Gaithersburg, MD) using 400 units of MMLV reverse transcriptase (GIBCO-BRL). Five l of each cDNA product was amplified by 35 to 40 PCR cycles (94ЊC for 30 s, annealing at 60ЊC for 60 seconds, and extension at 72ЊC for 90 s), using primers for EPO and EPOR as listed in the Table. However, to detect changes of expression with different treatments, cDNA products were amplified by only 25 to 30 cycles, and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) was used as a reaction standard (23). To confirm the purity of cell preparations, cDNA from each cell typeenriched cultures was amplified for neurofilament-M (a cell type-specific marker for neurons), GFAP (for astrocytes), B7-2 (CD86, for microglia), and myelin basic protein (for oligodendrocytes) (24, 25) . Ten l of each PCR product was analyzed by 1.4% agarose gel electrophoresis.
ELISA Analysis
Human astrocytes grown in T25 flasks (4 ϫ 10 6 cells/flask) were incubated with feeding medium containing cytokines for 6 to 48 h. Culture medium was changed into serum-free medium after washing with PBS 3 times and incubated for 24 h. Supernatants were collected and frozen at Ϫ70ЊC until the assay. EPO production in astrocyte culture supernatants was determined by using an ELISA kit specific for human EPO (R&D Systems), capable of detecting EPO at 2.5 mIU/ml. 
RESULTS
Expression of EPO and EPOR in Human Neurons, Astrocytes, Microglia, and Oligodendrocytes
Neuron-, astrocyte-, or microglia-enriched populations were isolated from primary cultures of human embryonic telencephalon, and oligodendrocyte-enriched population was isolated from human adult brain (Fig. 1) . Purity of each cell type population was better than 98% as evaluated by the presence of cell type-specific antigens as determined by immunostaining. Gene expression of each cell type was negative for other cell type-specific markers by RT-PCR. EPO mRNA was expressed only in astrocytes, while EPOR mRNA was recognized in neurons, astrocytes, and microglia (Fig. 2) . Neither EPO mRNA nor EPOR mRNA was expressed in human adult oligodendrocyte cultures (Fig. 2) . EPO gene expression was not demonstrated constitutively in neurons in normal unstimulated condition (Fig. 2) , nor in neurons treated with cytokines including IL-1␤, IL-6, TNF-␣, and neurotrophic factors NGF, BDNF, NT-3, FGF-2. In microglia, EPO expression could not be induced with proinflammatory cytokines, such as IL-1␤, IL-6, or TNF-␣ (data not shown).
Decreased Expression of EPO and EPOR in Astrocytes by Proinflammatory Cytokines
Effects of proinflammatory cytokines on EPO/EPOR expression in astrocytes were investigated. Human astrocytes were cultured in the presence of IL-1␤, IL-6, TNF-␣, or IL-10 for 6 h and the amount of EPO and EPOR transcripts was determined by RT-PCR analysis at 30 cycles. Human astrocytes incubated with proinflammatory cytokines (IL-1␤, IL-6, or TNF-␣) registered reduction in mRNA levels of EPO and EPOR, while IL-10 did not show any effect (Fig. 3A) . Time course effect of IL-6 on the expression EPO mRNA in human astrocytes was also studied. In the presence of IL-6 for 0, 1, 6, 12, 24 h, IL-6 expression was already decreased at 1 h and was not detected after 6 h (Fig. 3B) .
Increased Expression of EPOR in Neurons by TNF-␣ Treatment
Human neurons were cultured in the presence of IL-1␤, IL-6, TNF-␣, or IL-10 for 6 h and the amount of EPOR transcripts was determined by RT-PCR analysis at 25 cycles. EPOR gene expression was upregulated following TNF-␣ treatment while other cytokines did not alter the expression level (Fig. 4) .
EPO ELISA Study in Astrocytes
As shown in the RT-PCR analysis, it is evident that EPO gene expression was downregulated after activation with proinflammatory cytokines, such as IL-1␤, IL-6, and TNF-␣ (Fig. 3) . Next we determined EPO levels in the supernatants of astrocyte cultures stimulated with IL-1␤, IL-6, TNF-␣, and IL-10 using a specific EPO ELISA kit. In the time course analysis, EPO production was decreased from 6-h treatment with IL-6 and thereafter and the production was hardly detectable after 24 h (Fig. 5A) . EPO production in astrocytes treated with IL-1␤ or TNF-␣ was also decreased after 12-h treatment (Fig. 5B) . IL-10 treatment did not influence the EPO production level. EPO production was not detected in the culture supernatants of neuron-, microglia-, or oligodendrocyte-enriched cultures.
DISCUSSION
In the present study, gene expression of EPO and EPOR was examined in highly purified cultures of human neurons, astrocytes, microglia, and oligodendrocytes. To date no systematic study of EPO and EPOR in human nervous system is available and the present study is the first one to deal with the subject. Our results indicate that in human brain cells, the EPO message is detected only in astrocytes; however, expression of EPOR can be detected in neurons, astrocytes, and microglia. This study also confirms the results of previous studies in rat and mouse that show production of EPO by astrocytes and expression of EPOR in CNS neurons (7) (8) (9) 26) .
Previous studies have demonstrated that low oxygen concentration is a common regulatory signal of EPO production in liver, kidney, and brain (9, (27) (28) (29) . Furthermore, proinflammatory cytokines and phorbol ester, a protein kinase C activator, have been shown to inhibit EPO gene expression and protein production in human hepatoma cell lines (12, 13, 30) . In the present study, proinflammatory cytokines such as IL-1␤, IL-6, and TNF-␣ were found to decrease the EPO expression in human astrocytes in the normoxic state. Since EPO has been shown to exhibit trophic effects on neurons and support neuronal survival (4, 6, 8) , reduced EPO gene expression and EPO production in astrocytes by proinflammatory cytokines could result in unfavorably low neuronal survival.
It is worthy to note that TNF-␣ treatment increased EPOR expression in neurons and reduced EPO expression in astrocytes. This could represent a compensatory mechanism whereby neurons counteract the proinflammatory cytokine-mediated decrease in EPO production in astrocytes. This TNF-␣-induced EPOR expression in neurons may explain why expression of EPOR mRNA was increased in the ischemic penumbra in middle cerebral artery-occluded rats as TNF-␣ secretion may increase at the lesion site (5). On the other hand, EPOR expression was decreased in astrocytes after exposure to proinflammatory cytokines, as was EPO expression in astrocytes.
In the present study, EPOR expression was found constitutively in microglia, and proinflammatory cytokines such as IL-1␤, IL-6, or TNF-␣ did not cause any change in EPOR expression. Although previous studies have focused on mainly neurotrophic effects of EPO on rodent CNS neurons, it is time to investigate modulatory effects of EPO on astrocytes and microglia as well.
Together, the results of the present study suggest that proinflammatory cytokines have regulatory roles on EPO and EPOR expression in the CNS and should facilitate understanding of functional roles played by EPO and EPOR in the CNS in health and disease.
